| DAWN Stock | | | USD 12.26 0.05 0.41% |
This module uses fundamental data of Day One to approximate its Piotroski F score. Day One F Score is determined by combining nine binary scores representing 3 distinct fundamental categories of Day One Biopharmaceuticals. These three categories are profitability, efficiency, and funding. Some research analysts and sophisticated value traders use Piotroski F Score to find opportunities outside of the conventional market and financial statement analysis.They believe that some of the new information about Day One financial position does not get reflected in the current market share price suggesting a possibility of arbitrage. Check out
Day One Altman Z Score,
Day One Correlation,
Day One Valuation, as well as analyze
Day One Alpha and Beta and
Day One Hype Analysis.
At this time, Day One's
Short and Long Term Debt Total is very stable compared to the past year. As of the 16th of February 2025,
Short Term Debt is likely to grow to about 501.6
K, while
Net Debt is likely to drop (217.7
M). At this time, Day One's
Shareholders Equity Per Share is very stable compared to the past year. As of the 16th of February 2025,
Debt To Equity is likely to grow to 0, while
Book Value Per Share is likely to drop 2.10.
At this time, it appears that Day One's Piotroski F Score is Poor. Although some professional money managers and academia have recently criticized
Piotroski F-Score model, we still consider it an effective method of
predicting the state of the financial strength of any organization that is not predisposed to accounting gimmicks and manipulations. Using this score on the criteria to originate an efficient long-term portfolio can help investors filter out the purely speculative stocks or equities playing fundamental games by manipulating their earnings..
4.0
Piotroski F Score - Poor
| Change in Return on Assets | |
| Cash Flow Return on Assets | |
| Current Quality of Earnings (accrual) | |
| Long Term Debt Over Assets Change | |
| Change In Outstending Shares | |
Day One Piotroski F Score Drivers
The critical factor to consider when applying the Piotroski F Score to Day One is to make sure Day is not a subject of accounting manipulations and runs a healthy internal audit department. So, if Day One's auditors report directly to the board (not management), the managers will be reluctant to manipulate simply due to the fear of punishment. On the other hand, the auditors will be free to investigate the ledgers properly because they know that the board has their back. Below are the main accounts that are used in the Piotroski F Score model. By analyzing the historical trends of the mains drivers, investors can determine if Day One's financial numbers are properly reported.
Day One Biopharmaceu F Score Driver Matrix
One of the toughest challenges investors face today is learning how to quickly synthesize historical
financial statements and information provided by the company, SEC reporting, and various external parties in order to project the various growth rates. Understanding the correlation between Day One's different financial indicators related to revenue, expenses, operating profit, and net earnings helps investors identify and prioritize their investing strategies towards Day One in a much-optimized way.
Click cells to compare fundamentals
About Day One Piotroski F Score
F-Score is one of many stock grading techniques developed by Joseph Piotroski, a professor of accounting at the Stanford University Graduate School of Business. It was published in 2002 under the paper titled
Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers. Piotroski F Score is based on binary analysis strategy in which stocks are given one point for passing 9 very simple fundamental tests, and zero point otherwise. According to Mr. Piotroski's analysis, his F-Score binary model can help to predict the performance of low price-to-book stocks.
Day One Current Valuation Drivers
We derive many important indicators used in calculating different scores of Day One from analyzing Day One's financial statements. These drivers represent accounts that assess Day One's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Day One's important valuation drivers and their relationship over time.
| | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) |
| Enterprise Value | | 1.4B | 759.8M | 1.3B | 934.3M | 1.1B | 1.3B |
Day One ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Day One's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Day One's managers, analysts, and investors.
About Day One Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Day One Biopharmaceuticals's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Day One using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at
the intrinsic value of Day One Biopharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing
financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our
fundamental analysis page.
Pair Trading with Day One
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Day One position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Day One will appreciate offsetting losses from the drop in the long position's value.
The ability to find closely correlated positions to Day One could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Day One when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Day One - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Day One Biopharmaceuticals to buy it.
The correlation of Day One is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Day One moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Day One Biopharmaceu moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Day One can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
When determining whether Day One Biopharmaceu
offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Day One's
financial statements, including income statements, balance sheets, and cash flow statements, to assess its
financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Day One Biopharmaceuticals Stock.
Outlined below are crucial reports that will aid in making a well-informed decision on Day One Biopharmaceuticals Stock: Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost
the valuation of Day One. If investors know Day will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Day One listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share | Revenue Per Share | Return On Assets | Return On Equity |
The market value of Day One Biopharmaceu is measured differently than its book value, which is the value of Day that is recorded on the company's balance sheet. Investors also form their own opinion of Day One's value that differs from its market value or its book value, called intrinsic value, which is Day One's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Day One's market value can be influenced by many factors that don't directly affect Day One's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Day One's value and its price as these two are different measures arrived at by different means. Investors typically determine
if Day One is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Day One's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.